If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Journal of Nursing ScholarshipVolume 38 Issue 4, Pages 335 - 343 Published Online: 17 Nov 2006 © 2009 Sigma Theta Tau International Published with Sigma Theta Tau International, Honor Society of Nursing
Abstract | References | Full Text: HTML, PDF (Size: 250K) | Related Articles | Citation Tracking Genomics to Health Non-Hodgkin's Lymphoma as an Exemplar of the Effects of Genetics and Genomics Copyright 2006 Sigma Theta Tau International KEYWORDS
cancer genetics
•
genetic testing
•
genetics
•
genomics
•
lymphoma
•
oncology nursing
Journal of Nursing Scholarship, 2006; 38:4, 335-343. ©2006 Sigma Theta Tau International. ABSTRACTPurpose: To discuss the interface of genetics and genomics science in the identification and management of non-Hodgkin's lymphoma. The field of oncology is an exemplar of how the genomic revolution is influencing more individualized care and treatment of people with cancer and their families. Design: Integrated review of the cancer genetics and genomics literature. Methods: Published peer-reviewed research, conference proceedings, and peer-reviewed internet sites regarding the genetics and genomics of cancer and non-Hodgkin's lymphoma were reviewed, analyzed, and data synthesized. Findings: All malignancies have a genetic and genomic basis. Genetic and genomic breakthroughs are rapidly being applied to all aspects of cancer care including: (a) identification of at-risk individuals before disease occurs, (b) diagnosis and characterization of disease and its aggressiveness when it appears via gene expression, (c) and individualization of therapies over the disease course based on these new molecular technologies. Conclusions: Oncology nurses in every role, clinical subspecialty, and type of education are among the first nurses to integrate genetic and genomic information in such a broad context. This experience shows how genetic and genomic discoveries will interface with other health conditions and ultimately, will affect the practice of all nurses. Accepted for publication July 11, 2006. |